Beyond the limits of detection: Failure of PiB imaging to capture true Aβ burden

Movement Disorders

Volumn 28, Issue 3, 2013, Pages 406-

  Kalaitzakis, Michail E ^a   Pearce, Ronald K B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

CORPUS STRIATUM; DEMENTIA; DIFFUSE LEWY BODY DISEASE; HUMAN; LETTER; LIMIT OF DETECTION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME;

AMYLOID BETA-PEPTIDES; COGNITION; FEMALE; HUMANS; LEWY BODY DISEASE; MALE;

EID: 84875523592     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25307     Document Type: Letter

References (4)

1. Gomperts SN, Locascio JJ, Marquie M, et al. Brain amyloid and cognition in Lewy body diseases. Mov Disord. 2012;27:965-973.
2. Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM. Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes. Neurobiol Dis. 2011;41:377-384.
3. Edison P, Rowe CC, Rinne JO, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry. 2008;79:1331-1338.
4. Gomperts SN, Rentz DM, Moran E, et al. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008;71:903-910.